hindbio science share price Management discussions

Industry structure and developments

Human Recombinant Erythropoietin being imported into India is facing tough competition from Indian manufacturers owing to the drop-in rupee value against the US dollar. The company could not import any quantities from China after the pandemic. Our business has hit rock bottom due to high costs of product and logistics.

Performance

Segment–wise or product-wise performance

The company has been exporting formulations to Srilanka and creating a decent revenue, but due to socioeconomic crisis in Srilanka our exports also declined.

Outlook

During the year under review, the business operations of the company are effected to large extent, we could not promote sales in the year.

The company has applied for renewal of the License which expired in April 2022 but has decided not to renew the license as the DCGI has increased the renewal fee drastically to US$15000 per strength which Is not feasible to the company.

Risks and concerns

The company ‘s prime business is Exports only toSrilanka but concerned of non timely payments for each consignment due to socio economic crisis in Srilanka and receiving the payments in INR instead of USD due to Indian credit line facility granted to Srilanka which is taking almost 6 months after the shipment.

Internal control systems and their adequacy

The internal control systems are adequate to the size and nature of operations of the company.

Discussion on financial performance with respect to operational performance

Material developments in Human Resources / Industrial Relations front, including number of people employed

Our Company continues to have cordial relations with its employees and other stakeholders.

Key Financial Ratios:

Ratios	Numerator	Denominator	Year ended 31^stMarch 2023	Year ended 31^stMarch 2022	% of Variance
Current Ratios	Current Assets	Current Liabilities	0.61	0.48	27(^a)
Debt - Equity Ratio	Debt	Net Worth	NA	NA	NA
Debt Service Coverage	Earnings before	Interest expense +	NA	NA	NA
Ratio	depreciation, interest and tax	Principal repayment
Return on Equity Ratio (ROE)	Net Profits after taxes – Preference Dividend	Average Shareholders Equity	-0.01	-0.49	98(b)
Inventory turnover ratio	Sales of Goods	Average ^Inventory	NA	NA	NA (c)
T333rade Receivables turnover ratio	Sales of Goods	Average Trade Receivable	^3.13	0.78	300(d)
Trade payables turnover ratio	Purchases +Other expenses and Additions to PPE	Average Trade Payables	17.23	4.89	252(e)
Net capital turnover ratio	Sales of Goods	current assets - current liabilities	-1.65	-0.75	120
Net profit ratio	Net profit	Sales of Services	-0.04	-1.19	236(f)
Return on Capital employed	Earnings before interest and taxes	Average Capital Employed	-0.02	-0.49	96(g)
Return on Investments	Income generated from Deposit	Average value of Deposits	NA	NA	NA

DISCLOSURE OF ACCOUNTING TREATMENT:

The Company has complied with the appropriate accounting policies and has ensured that they have been applied consistently. There have been no deviations from the treatment prescribed in the Accounting Standards notified under Section 133 of the Companies Act, 2013.

	For and on behalf of the Board of Directors
	Hindustan Bio Sciences Limited
	Sd/-
	Venkata Rama Mohan Raju Jampana
Place: Hyderabad	Managing Director
Date: 31-07-2023	(DIN: 00060800)

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

hindbio science share price Management discussions

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.